TABLE I. Summary of dengue virus (DENV)- and Zica virus (ZIKV)-infected patients enrolled in the study.
| Patients ID | Age | Gender | ZIKV IgG | DENV IgG |
| P01 | 20 | F | POS | NEG |
| P05 | 20 | F | POS | NEG |
| P11 | 18 | F | POS | NEG |
| P13 | 15 | F | POS | NEG |
| P41 | 20 | F | POS | NEG |
| P03 | 28 | F | POS | POS (DV3,4) |
| P15 | 18 | F | POS | POS (DV3,4) |
| P67 | 28 | F | POS | POS (DV1,2,3,4) |
| P69 | 17 | F | POS | POS (DV3,4) |
| P71 | 20 | F | POS | POS (DV3,4) |
| P02 | 47 | F | NEG | POS (DV2) |
| P132 | 37 | M | NEG | NEG |
| P322 | 66 | F | NEG | POS (DV1) |
| P481 | 16 | M | NEG | POS (DV2) |
| P491 | 30 | M | NEG | POS (DV3) |
| P306 | 47 | F | NEG | POS (DV3) |
| P122 | 36 | F | NEG | POS (DV4) |
| P156 | 64 | M | NEG | POS (DV4) |
| P234 | 24 | F | NEG | POS (DV4) |
F: female; IgG: immunoglobulin G; M: male; NEG: negative; POS: positive.